Simplex Trading’s Krystal Biotech KRYS Stock Holding History

Simplex Trading’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.9K	Sell	50 -243	-83%	-$64.7K	﹤0.01%	7124
2025 Q4	$72.2K	Buy	+293	New	+$61.7K	﹤0.01%	5310
2023 Q4	–	Sell	-27	Closed	-$2.99K	–	9351
2023 Q3	$3K	Sell	27 -5,162	-99%	-$630K	﹤0.01%	7914
2023 Q2	$609K	Buy	+5,189	New	+$530K	﹤0.01%	3103
2022 Q2	–	Sell	-26	Closed	-$1.62K	–	10545
2022 Q1	$1K	Buy	+26	New	+$1.62K	﹤0.01%	10094
2021 Q4	–	Sell	-5,025	Closed	-$292K	–	10949
2021 Q3	$360K	Sell	5,025 -500	-9%	-$29.6K	﹤0.01%	4616
2021 Q2	$375K	Buy	+5,525	New	+$386K	﹤0.01%	4609
2020 Q4	–	Sell	-1,231	Closed	-$61.5K	–	8724
2020 Q3	$52K	Buy	1,231 +1,169	+1,885%	+$50.8K	﹤0.01%	5568
2020 Q2	$2K	Buy	+62	New	+$2.98K	﹤0.01%	7254

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's KRYS Position: Q1 2026 in Review

Simplex Trading reduced its Krystal Biotech (KRYS) stake by 83% in Q1 2026, selling an estimated $64.7K and leaving 50 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7124.

Simplex Trading first reported a position in KRYS in Q2 2020 and has held it in 9 quarters since. The position peaked at $609K in Q2 2023. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

Simplex Trading held 50 shares of Krystal Biotech worth $12.9K as of Q1 2026.
Simplex Trading sold 243 Krystal Biotech shares in Q1 2026, an estimated $64.7K.
Krystal Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7124 holding.
Simplex Trading first reported a position in Krystal Biotech in Q2 2020 and has held it in 9 quarters since.
Simplex Trading's Krystal Biotech position peaked at $609K in Q2 2023.
367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.